首页 > 市场调查报告书 > 製药

麻醉

市场调查报告书

商品编码

1461446

七氟醚市场，按应用、配销通路和地区 - 规模、份额、前景和机会分析，2024 年至 2031 年

Sevoflurane Market, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

出版日期: 2024年03月12日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2024 年，全球七氟醚市值将达到 4.007 亿美元，预计在预测期内（2024-2031 年）复合年增长率为 4.4%。

报告范围		报告详情
基准年：	2023年	2023/2024 年市场规模：	4.007 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测期间 2023/2024 至 2030/2031 年复合成长率：	4.40%	2030/2031 价值预测：	5.422 亿美元

2024 年全球七氟醚市场价值（百万美元），按地区划分

七氟烷是一种具有甜味、不易燃、高度氟化的甲基异丙醚，用作全身麻醉诱导和维持的吸入性麻醉剂。它是继地氟烷之后起效最快的挥发性麻醉剂。

市场动态

市场参与者专注于推出新技术，以帮助透过吸入器提供麻醉，这可能有助于预测期内全球七氟醚市场的成长。例如，2022 年 4 月，全球领先的医疗技术公司 GE Healthcare 宣布，其 Aisys CS2 麻醉输送系统上用于全身麻醉输送的潮气末 (Et) 控制软体已获得 FDA 的上市前批准 (PMA)。和药物管理局（FDA）。在美国，GE Healthcare 是唯一一家获准提供具有呼气末浓度控制的全身麻醉的製造商。

需要麻醉的美容手术数量不断增加，预计将推动全球七氟醚市场的成长。例如，2022 年 4 月，专门致力于脸部和身体美容整形手术和美容医学的世界领先协会美容协会发布了年度美容整形手术统计数据，该统计数据显示，由于使用以下方法获得的资料，2021 年美国美容整形手术增加协会新的、更准确的数位技术。资料显示，脸部、乳房和身体的手术数量大幅增加。自 2020 年以来，腹部整形术、丰臀术和抽脂术在美国的受欢迎程度均猛增了 63%。

越来越多地推出回收吸入麻醉剂的技术预计将推动预测期内的成长。例如，2020 年 7 月，全球无菌药物生产和交付领域的领导者 Baxter International Inc. 宣布与医疗技术公司 ZeoSys Medical 签署正式协议，将捕获和回收麻醉气体的技术商业化。根据协议条款，百特将拥有全球分销权和在欧洲以外商业化该技术的独家许可，以及收购 ZeoSys Medical 的独家选择权。

研究的主要特点：

本报告对全球七氟醚市场进行了深入分析，提供了预测期（2024-2031）的市场规模，以 2023 年为基准年。
它阐明了不同细分市场的潜在收入机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、区域前景以及领先企业采取的竞争策略的重要见解。
它根据以下参数介绍了全球七氟烷市场的领先参与者 - 公司概况、财务绩效、产品组合、地理分布、分销策略、主要发展和策略以及未来计划。
该报告的见解将使行销人员和公司管理当局能够就未来的产品推出、技术升级、市场扩张和行销策略做出明智的决策。
全球七氟醚市场报告迎合了该行业的各种利益相关者，包括投资者、供应商、製造商、分销商、新进业者和金融分析师。
利害关係人可以透过用于分析全球七氟醚市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
欧洲
德国
英国
法国
义大利
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
澳洲
韩国
东协
亚太地区其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
南非
中非
北非

第 8 章：竞争格局

公司简介
- Abbott Laboratories
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceuticals Limited

第 9 章：分析师建议

命运之轮
分析师观点
连贯的机会图

第 10 章：部分

参考
研究方法论

简介目录

Product Code: CMI5031

The global sevoflurane market is estimated to be valued at USD 400.7 Mn in 2024 and is expected to exhibit a CAGR of 4.4% during the forecast period (2024-2031).

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 400.7 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	4.40%	2030/2031 Value Projection:	US$ 542.2 Mn

Global Sevoflurane Market Value (USD MN), by Region, 2024

Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether that is used as an inhalational anesthetic for general anesthesia induction and maintenance. It is the fastest-acting volatile anesthetic after desflurane.

Market Dynamics

Market players are focused on launching new technology to help delivery of anesthesia through inhalers, this could contribute to the growth of the global sevoflurane market over the forecast period. For instance, in April 2022, GE Healthcare, a leading global medical technology company, announced that its end-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2 Anesthesia Delivery System has received pre-market approval (PMA) from the U.S. Food and Drug Administration (FDA). In the U.S., GE Healthcare is the only manufacturer approved to provide general anesthesia with end-tidal concentration control.

Increasing number of aesthetic surgeries requiring anesthesia, is expected to drive the growth of global sevoflurane market. For instance, in April 2022, The Aesthetic Society, world's leading association dedicated solely to facial and body aesthetic plastic surgery and cosmetic medicine issued its annual Aesthetic Plastic Surgery Statistics, which revealed that aesthetic plastic surgery increased in 2021 in U.S. owing to data acquired using the Society's new, more accurate digital technology. The data shows a large growth in procedures for the face, breasts, and body. Abdominoplasty, buttock augmentation, and liposuction have all seen a 63% surge in popularity since 2020 in U.S. Breast augmentation, augmentation/breast lift, and breast lift/reduction treatments all increased by 48%.

Increasing launches of technology to recycle inhaled anesthetics is expected to fuel the growth over forecast period. For instance, in July 2020, Baxter International Inc., a global leader in the production and delivery of sterile medications, announced a formal agreement with ZeoSys Medical, a medical technology company, to commercialize technology to capture and recycle anesthetic gases. Baxter will have worldwide distribution rights and an exclusive license to commercialize the technology outside of Europe, as well as an exclusive option to acquire ZeoSys Medical, under the terms of the agreement.

Key features of the study:

This report provides an in-depth analysis of global sevoflurane market, provides market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global sevoflurane market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, Baxter, Piramal Pharma Solutions, Manus Aktteva Biopharma LLP, Maruishi Pharmaceutical Co.,Ltd., Lunan Pharmaceutical Group, Abbvie, Wellona Pharma, Rewine Pharmaceutical, and Troikaa Pharmaceuticals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global sevoflurane market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global sevoflurane market.

Detailed Segmentation:

Global Sevoflurane Market, By Application:
- Induction
- Maintenance
Global Sevoflurane Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Sevoflurane Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Abbott Laboratories
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceuticals Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Porter's Analysis
Industry Trends
Key Highlights
Epidemiology
Reimbursement Scenario
Regulatory Scenario
Product Launch and Approvals
Acquisition and Collaboration Scenario

4. Global Sevoflurane Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Impact of COVID-19 on demand and supply of sevoflurane
Impact of COVID-19 on the overall healthcare sector

5. Global Sevoflurane Market, By Application, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Sevoflurane Market, By Distribution Channel, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Sevoflurane Market, By Region, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
North America
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017-2030 (US$ Mn)
South Africa
Central Africa
North Africa

8. Competitive Landscape

Company Profiles
- Abbott Laboratories*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceuticals Limited